Related Experiment Videos

WIP-ing out atherosclerosis with autophagy

Anna Brichkina1, Dmitry V Bulavin

  • 1Institute of Molecular and Cell Biology, Proteos, Singapore.

Autophagy
|August 17, 2012
PubMed

Insights

Scientists found that PPM1D/WIP1 phosphatase regulates atherosclerosis by controlling macrophage foam cell formation. Modulating the PPM1D-ATM-MTOR pathway and autophagy may offer new treatments for this cardiovascular disease.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Pathophysiology

Background:

  • Atherosclerosis is a leading cause of global morbidity, including coronary and cerebrovascular diseases.
  • Current therapeutic strategies are limited by an incomplete understanding of the molecular underpinnings of atherosclerosis.
  • Identifying novel molecular targets is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of PPM1D/WIP1 phosphatase in the molecular mechanisms of atherosclerosis.
  • To elucidate the signaling pathways and cellular processes regulated by PPM1D in the context of atherosclerosis.
  • To explore the potential of targeting PPM1D-mediated pathways for therapeutic intervention.

Main Methods:

  • Utilized mouse models with targeted deletion of the Ppm1d gene.
  • Investigated lipid droplet accumulation in macrophages and foam cell formation.
  • Analyzed the involvement of the ATM-MTOR pathway and selective autophagy.
  • Assessed the impact on cholesterol efflux from macrophage foam cells.

Main Results:

  • Deletion of Ppm1d suppressed lipid droplet accumulation in macrophages, preventing foam cell formation.
  • PPM1D-mediated regulation of atherosclerosis involves the ATM-MTOR pathway and selective autophagy.
  • Modulation of autophagy is critical for regulating cholesterol efflux in macrophage foam cells.
  • Inhibition of PPM1D activity attenuated the development of atherosclerotic plaques in mice.

Conclusions:

  • PPM1D/WIP1 phosphatase is a key regulator of atherosclerosis development.
  • The PPM1D-ATM-MTOR pathway and selective autophagy are critical for controlling macrophage cholesterol homeostasis.
  • Targeting the PPM1D-ATM-MTOR pathway offers a potential therapeutic strategy for atherosclerosis at various disease stages.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Inflammation01:38

Inflammation

Overview